Showing results (21-30 of 172) with videos related to
Sort By:
Pageof 18
Current Opinion in Investigational Drugs (London, England : 2000)|December 24, 2005
Interleukin-2 for the treatment of melanomaAhmad A Tarhini, Sanjiv S AgarwalaExpert Opinion on Biological Therapy|September 1, 2004
First International Symposium on Melanoma and Other Cutaneous MalignanciesAhmad A Tarhini, Sanjiv S AgarwalaHematology/Oncology Clinics of North America|June 2, 2014
Melanoma adjuvant therapyAhmad A Tarhini, Prashanth M ThalanayarCancers|August 26, 2023
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the FieldIslam Eljilany, Ella Castellano, Ahmad A TarhiniExpert Review of Clinical Immunology|August 14, 2023
Clinical updates in neoadjuvant immunotherapy for melanoma before surgeryMariam Saad, Ella Castellano, Ahmad A TarhiniCancer Journal (Sudbury, Mass.)|March 25, 2024
Treatment of Stage III Resectable Melanoma-Adjuvant and Neoadjuvant ApproachesAhmad A Tarhini, Ella Castellano, Islam EljilanyImmunotherapy|June 23, 2021
Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanomaAhmad A Tarhini, Ila Joshi, Fiona GarnerAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant TherapyAhmad A Tarhini, Paul Lorigan, Sancy LeachmanSeminars in Oncology|May 13, 2015
Immune checkpoint blockade and interferon-α in melanomaImran Rafique, John M Kirkwood, Ahmad A TarhiniRevue De Pneumologie Clinique|December 3, 2014
[Pleuro-pericarditis developed under a leflunomide therapy]F Vandenbos, M Figueredo, A Tarhini, et al.Pageof 18